Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein

Biotech company Mammoth Biosciences, which uses gene-editing Crispr technology for diagnostic and discovery applications, announced Wednesday that it has signed an exclusive deal with University of California Berkeley to license a new class of Crispr proteins for use in its product line.